Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-05
1997-10-07
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 4242041, 4242051, A61K 3912, A61K 39145, A61K 3900, A61K 3938
Patent
active
056745028
ABSTRACT:
This disclosure relates to methods and compositions for stimulating in an individual an influenza A virus protective response which is subtype cross-protective. Influenza A virus NS1 protein, or a T cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response.
REFERENCES:
patent: 4803072 (1989-02-01), Dalton et al.
Wraith, David C. et al., "Purified Influenza Virus Nucleoprotein Protects Mice from Lethal Infection," J. Gen. Virol. 68:433-440 (1987).
Bennink, Jack R. et al., "Anti-Influenza Virus Cytotoxic T Lymphocytes Recognize the Three Viral Polymerases and a Nonstructural Protein: Responsiveness to Individual Viral Antigens Is Major Histocompatibility Complex Controlled," J. Gen. Virol. 61(4):1098-1102 (1987).
Yamada, Akio et al., "Influenza Virus Hemagglutinin-Specific Cytotoxic T Cell Response Induced by Polypeptide Produced in Escherichia coli," J. Exp. Med. 162:663-674 (1985).
Kuwano, Koichi et al., "Active Immunization Against Virus Infections Due to Antigenic Drift by Induction of Crtossreactive Cytotoxic T Lymphocytes," J. Exp. Med. 169:1361-1371 (1989).
Kuwano, Koichi et al., "Ha2 Subunit of Influenza A H1 and H2 Subtype Viruses Induces a Protective Cross-Reactive Cytotoxic T Lymphocyte Resonse," J. Immunol. 140:1264-1268 (1988).
Kuwano, Koichi and Ennis, Francis, "Cross-reactive protection against influenza A virus infections by an NS2-specific CTL clone," Chemical Abstracts 113: Abstract No.: 130459C, p. 499 (1990).
Kingsman, Genetic Engineering, Chapter 12, Blackwell Scientific Publications (Oxford, GB), 1988.
Young et al., "Efficient Expression of Influenza Virus NS1," PNAS 80:6105-6109 (1983).
Smith, Geoffrey L. et al., "Synthesis and Cellular Location of Ten Influenza Polypeptides Individually Expressed by Recombinant Vaccinia Viruses," Virology 160(2):336-345 (1987).
Shaw, Michael W. et al., "Immunologic Studies on the Influenza A Virus Nonstructural Protein NS.sub.1," J. Exp. Med. 156:243-254 (1982).
Kuwano, Koichi et al., "Cross-Reactive Protection Against Influenza A Virus Infections," Virology, 178:174-179 (1990).
Cossins, Judy et al., "Precise Prediction of a K.sup.k -Restricted Cytotoxic T Cell Epitope in the NS1 Protein of Influenza Virus Using an MHC Allele-Specific Motif," Virology, 19 (31):289-295 (1993).
Hackett, Charles J. et al., "Influenza virus infection elicits class II major histocompatiility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein," J. of General Virology, 73:1339-1343 (1992).
Smith Lynette F.
University of Massachusetts Medical Center
LandOfFree
Cross-reactive influenza a immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-reactive influenza a immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive influenza a immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2354592